Follow The Filings

BLLN

Earnings company data as of 4:46 AM ET 10/15

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 8 Dec EPS 0.18 — —
Rev — — —

Insider trades

Open-market buys and sales by BLLN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BLLN insider trades
  • $3.2M bought by 6 insiders
  • None no sales outside a trading plan
  • $51.3M sold by 6 insiders under 10b5-1 plans
  1. Oguzhan Atay CEO
    Planned sale
    $1.1M 11,000 shares at $99.14
    Traded Oct 14–15 Filed Oct 16
    ↗
  2. Oguzhan Atay CEO
    Planned sale
    $1.8M 19,334 shares at $94.31
    Traded Oct 12 Filed Oct 14
    ↗
  3. David Tsao Chief Technology Officer
    Planned sale
    $2.2M 20,000 shares at $108.15 95% of stake
    Traded Oct 5 Filed Oct 7
    ↗
  4. Bosch John Roderick Ten SVP of Laboratory Operations
    Planned sale
    $298K 2,834 shares at $105.15 13% of stake
    Traded Oct 5 Filed Oct 7
    ↗
  5. Oguzhan Atay CEO
    Planned sale
    $1.3M 10,999 shares at $120.64
    Traded Sep 28 Filed Sep 30
    ↗
  6. David Tsao Chief Technology Officer
    Planned sale
    $417K 3,333 shares at $125.00 77% of stake
    Traded Sep 24 Filed Sep 28
    ↗
  7. Bosch John Roderick Ten SVP of Laboratory Operations
    Planned sale
    $170K 1,416 shares at $120.00 6% of stake
    Traded Sep 24 Filed Sep 28
    ↗
  8. Bosch John Roderick Ten SVP of Laboratory Operations
    Planned sale
    $151K 1,416 shares at $106.61 5.7% of stake
    Traded Sep 21 Filed Sep 23
    ↗
  9. Thomas P. Lynch See Remarks
    Planned sale
    $3.9M 35,112 shares at $110.33 98% of stake
    Traded Sep 17 Filed Sep 21
    ↗
  10. Oguzhan Atay CEO
    Planned sale
    $3M 30,331 shares at $99.91
    Traded Sep 14 Filed Sep 16
    ↗
  11. David Tsao Chief Technology Officer
    Planned sale
    $2M 20,000 shares at $98.77 95% of stake
    Traded Sep 9 Filed Sep 11
    ↗
  12. Bosch John Roderick Ten SVP of Laboratory Operations
    Planned sale
    $138K 1,416 shares at $97.54 5.4% of stake
    Traded Sep 9 Filed Sep 11
    ↗
  13. Thomas P. Lynch See Remarks
    Planned sale
    $2M 20,000 shares at $99.99 97% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  14. David Tsao Chief Technology Officer
    Planned sale
    $1M 10,000 shares at $100.00 91% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  15. Bosch John Roderick Ten SVP of Laboratory Operations
    Planned sale
    $142K 1,417 shares at $100.00 5.1% of stake
    Traded Aug 25 Filed Aug 27
    ↗

Also filed in the last 12 months, not counted as buying or selling: 142 other transactions, 41 option exercises, 30 conversions, 10 stock grants, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.